Home
Home

Human Genome Sciences

News

HGS investors shrug off a mid-stage cancer failure
Fierce Biotech
»

News

Big Biotech M&A Targets: Who Could Follow Astellas' $3.5B Bid for OSI?
BNET Pharma
»

News

Five Biotech Takeout Targets
Minyanville
»

News

Lower Q4 Loss for Human Genome
Yahoo/Zacks.com
»

News

Our Top Five Biotech Takeout Picks
Morningstar
»

News

HGSI Pipeline Bigger than Earnings
Yahoo/Zacks.com
»

News

UK court overturns GSK patent for lupus drug
FT.com
»

News

Biotech's Movers and Shakers 2009: BioBuzz
TheStreet.com
»

News

2009 Biotech Cheers and Jeers
Motley Fool
»

News

Human Genome Sciences Looks Ready to Break Out
Seeking Alpha
»